Chirality最新文献

This study has been carried out to extend the validation of an amino alcohol catalyst in the asymmetric transfer hydrogenation (ATH) of ketones. Previously, the catalyst was tested in asymmetric addition to several aromatic aldehydes with good to excellent results. After having optimized the reaction conditions and tested different amino residues, the best catalyst was tested in ATH of various aromatic ketones, leading to generally high yields (up to > 95%) and moderate to good enantioselectivities (ee 24%–69%). Moreover, considering the lack of examples of recoverable and reusable amino alcohol–based nanostructured catalysts for the ATH, the catalyst of choice was immobilized on proper functionalized superparamagnetic core–shell magnetite–silica nanoparticles and employed in an ATH reaction in semi-homogeneous phase. The obtained nanocatalyst exhibited a moderate catalytic efficiency in the ATH, that remains unchanged in the three catalytic cycles performed, even if noticeably worse than in the homogeneous counterpart.

By utilizing β-cyclodextrin (β-CD) and bovine serum albumin (BSA) as chiral selectors, a simple method was employed to fabricate an electrochemical sensor that modified with aminoized multiwall carbon nanotubes (NH2-MWCNT) and silver nanoparticles (AgNPs). The appearance and structure of the chiral sensor were characterized through X-ray powder diffraction, scanning electron microscopy, transmission electron microscope, Fourier transform infrared spectroscopy, ultraviolet–visible spectrophotometer, and X-ray photoelectron spectroscopy. The electrochemical chiral recognition behavior of the phenylalanine (Phe) enantiomer was achieved by differential pulse voltammetry. The working chiral recognition is based on the “three-point action principle.” The hydrogen bond between chiral selectors and Phe is the key to chiral recognition. Under the optimal experimental conditions, the oxidation peak current ratio of D-Phe to L-Phe (ID/IL) was 1.71. In the linear range of 3–15 mM, the detection limits of D-Phe and L-Phe are 4.62 and 5.23 μM (S/N = 3), respectively. It is noteworthy that the sensor possessed good stability and reproducibility.

Molecular docking analysis of linalool interaction with mitogen-activated protein kinase 1 (MAPK1) provides valuable insights into the potential binding mechanisms and affinity of this interaction. Linalool, a naturally occurring terpene alcohol, has been the subject of increasing interest due to its diverse pharmacological properties, including anti-inflammatory, antioxidant, and anticancer activities. MAPK1 is a crucial signaling protein involved in various cellular processes, including cell proliferation, differentiation, and survival. Using MOE software, we conducted a stereoisomer analysis of (R)- and (S)-linalool in our study. After docking, the ligand was ranked according to their binding energy and the best lead compound was selected based on the highest binding energy. The results showed that the S-linalool isomer showed superior anticancer activity, while the R-linalool molecule showed less activity. This interaction could provide insights into linalool's potential therapeutic applications, highlighting its diverse pharmacological properties.

Dibenzoyl-L-tartaric acid (L-DBTA) is a crucial compound in the synthesis of chiral molecules, particularly within the pharmaceutical industry. Ensuring the enantiomeric purity of L-DBTA is essential for regulatory compliance, quality control, and process optimization. To achieve this, a high-performance liquid chromatography (HPLC) method was developed and validated for determining the D-DBTA content in L-DBTA. The method validation adhered to ICH Q2(R2) guidelines, covering parameters such as system suitability, solution stability, robustness, linearity, range, limit of detection (LOD), limit of quantification (LOQ), accuracy, and precision. HPLC separation was performed using a Chiral PAK IA column (250 × 4.6 mm, 5.0 μm) with an isocratic mobile phase consisting of n-heptane, isopropanol (IPA), and trifluoroacetic acid (900:100:1 v/v/v). The column temperature was maintained at 40°C, and the sample cooler was kept at ambient conditions. Detection was carried out at 230 nm, achieving a resolution greater than 1.5 between L-DBTA and D-DBTA. The method demonstrated excellent linearity over a range of 30%–200% of the specification limit, with accuracy and range established from the LOQ level to 200%. Solution stability was confirmed for 1 day at room temperature, and precision was validated at both the LOQ and 100% levels. All validation parameters met the acceptance criteria, confirming the method's suitability for routine testing and batch release at quality control sites. This HPLC method is both sensitive and selective, ensuring the reliable determination of chiral purity in L-DBTA and its impurities.

This article reports the synthesis of a molecularly imprinted phenolic formaldehyde resin for the selective recognition of the cationic S-enantiomer of venlafaxine. The resin was developed through the condensation polymerization of p-hydroxybenzoic acid (4-HBA) and 4-nitrophenol (4-NP) with formaldehyde in an acidic medium. The resultant polymer was reduced to introduce amino groups into the polymer to obtain a dual-functional resin with amino and carboxylic groups (CA-P). After the uptake of S-VF, glutaraldehyde cross-linking stabilized the resin and formed its enantioselective cavities. Adsorption studies showed that optimum conditions occurred at pH 7, whereas the maximum adsorption capacity was 420 mg/g according to the Langmuir isotherm. The selectivity coefficient of S-VF-IP was 13 times that of NIP, confirming that the imprinting process indeed occurred. Chiral separation experiments using the SV-imprinted polymer (S-VF-IP) column resulted in 98% enantiomeric excess for R-VF, whereas the respective NIP did not provide any enantioselectivity. These results show a great possibility of the developed resin in efficient enantioselective separation and offer a promising method for the purification of chiral drugs from racemic mixtures in pharmaceutical applications.

The simultaneous presence of natural and magnetic optical activity in chiral samples is a very interesting occurrence, but it may lead to incorrect data interpretation if appropriate care is not taken. Moving from simple but general principles, here we show which effects are possible and which are not in such cases.

An enantioselective voltammetric sensor (EVS) comprising a paste electrode made of graphitized thermal Carboblack C (CBPE) modified with a Ni(II) complex based on (S)-(2-aminomethyl)pyrrolidine and 3,5-di-tert-butylsalicylaldehyde was developed for the recognition and determination of naproxen (Nap) enantiomers. The proposed sensor was characterized by scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS-SEM), Fourier-transform infrared spectroscopy (FT-IR), molecular dynamics and quantum chemical simulations, electrochemical impedance spectroscopy (EIS), and cyclic voltammetry (CV) methods. Using the differential pulse voltammetry (DPV), the CBPE@(S)-Ni sensor was found to have good selectivity for Nap enantiomers (i_p1S/i_p1R = 1.43, i_p2S/i_p2R = 1.27 for the first/second peaks, respectively). The sensor demonstrates the highest sensitivity to (S)-Nap (6.44 and 6.90 μA/mM for the first and second peaks). The linear concentration range is from 5.0 × 10⁻⁵ to 1 × 10⁻³ M and from 2.0 × 10⁻⁴ to 1 × 10⁻³ M for (S)- and (R)-Nap, respectively, where the detection limits for the first and second peaks are 5.31 × 10⁻⁷ M and 4.96 × 10⁻⁷ M for (S)-Nap and 7.40 × 10⁻⁷ and 6.79 × 10⁻⁷ for (R)-Nap. The suggested sensor was successfully tested for the determination of Nap enantiomers in mixtures, in biological fluids, and in medicinal drug forms. In all the cases, the relative standard deviation (RSD) does not exceed 4.7%; the recovery percentage is in the range of 99.2%–101.3%.

In the fields of pharmaceuticals and biopharmaceuticals, chiral liquid chromatography techniques including high-performance liquid chromatography and ultra-performance liquid chromatography are frequently used to isolate, identify, separate, and quantify chiral isomers, including enantiomers and diastereomers (stereoisomers), due to the significant differences in biological activity and therapeutic effects of stereoisomers. The authors have provided a comprehensive overview of the fundamental principles necessary for using liquid chromatography to separate and accurately estimate chiral compounds that exhibit stereoisomerism (both enantiomers and diastereomers). The development strategies outlined include the selection of chromatographic conditions, optimization of sample preparation, evaluation of degradation pathways, establishment of system suitability criteria, and execution of method validation studies. Additionally, this article supports the development of robust and stability-indicating methods by applying one factor at a time and design of experiments concepts for chiral drugs and their chiral impurities in pharmaceuticals and biopharmaceuticals. The method validation attributes essential to evaluate the characteristics of the developed method were discussed in this write-up. The validation parameters include specificity, linearity, detection limit, quantitation limit, accuracy, precision, solution stability.